NF-κB is activated in many cancers; it plays a critical role in deregulation of cell growth, angiogenesis, and tendency of tumours to metastasize [38–40], acting as one of the major signalling pathways responsible for cancer cell invasion and possibly functioning as a target for cancer therapy [41]. The gene discussed is NFKB1; the disease is neoplasm.